Revolutionary Silicone Patch Could Transform Melanoma Detection Without Biopsies

A new silicone patch developed by University of Michigan researchers could change how melanoma is detected. The ExoPatch uses tiny microneedles to collect skin samples without drawing blood or requiring a biopsy. Early tests suggest it can tell the difference between healthy tissue and melanoma with noticeable accuracy. The ExoPatch works by picking up exosomes—small particles containing DNA and RNA—from the skin's top layer. Its star-shaped microneedles, coated in a special gel, penetrate only the epidermis. This avoids the need for invasive procedures while still gathering key biological markers.

Tests on pig and mouse skin showed promising results. Melanoma samples produced a line 3.5 times darker than healthy tissue, making detection clearer. Researchers believe the same technology could eventually be adapted for other cancers, including lung, breast, and prostate.

Despite the progress, the project remains in preclinical development. As of April 2026, no official timeline has been set for human trials. A planned pilot study with volunteers has yet to be announced, leaving the next steps uncertain. If successful, the ExoPatch could allow people to test for melanoma at home quickly and painlessly. The device's ability to detect cancer early, without blood or tissue removal, marks a potential shift in diagnostic methods. Further validation in human trials will determine its real-world effectiveness.